Mardi C. Boer

630 citations
17 papers · 422 indexed · h-index 11
Topics
SARS-CoV-2 and COVID-19 Research (6 papers)Immune responses and vaccinations (5 papers)Tuberculosis Research and Epidemiology (4 papers)

In The Last Decade

Mardi C. Boer

16 papers receiving 413 citations

Peers

Mardi C. Boer
Comparison fields: 5 of 72
  • Immunology 237
  • Infectious Diseases 167
  • Epidemiology 94
  • Molecular Biology 55
  • Surgery 51
Replace Manuela Zlamy with:
Manuela Zlamy Austria
John J. Erickson United States
Enrique Chacón‐Cruz United States
Maria Célia Cervi Brazil
Marieke van der Heiden Netherlands
Alfred T. Harding United States
Momodou Cox Gambia
David Eduardo Meza-Sánchez Mexico
Simon Blankley United Kingdom
Tyler D. Bold United States
Mardi C. Boer relative to Manuela Zlamy Austria Manuela Zlamy's profile →
Citations per field
00.5×
Manuela Zlamy · 1×
Citations per year

Countries citing papers authored by Mardi C. Boer

Since Specialization
Citations

This map shows the geographic impact of Mardi C. Boer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mardi C. Boer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mardi C. Boer more than expected).

Fields of papers citing papers by Mardi C. Boer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mardi C. Boer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mardi C. Boer. The network helps show where Mardi C. Boer may publish in the future.

Co-authorship network of co-authors of Mardi C. Boer

This figure shows the co-authorship network connecting the top 25 collaborators of Mardi C. Boer. A scholar is included among the top collaborators of Mardi C. Boer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mardi C. Boer. Mardi C. Boer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
#WorkIndexed citations
1 1
2 2
3 2
4 10
5 20
6 11
7 44
8 1
9 26
10 116
11 46
12 26
13 32
14 38
15 22
16 0
17 25

About Mardi C. Boer

Mardi C. Boer is a scholar working on Infectious Diseases, Immunology and Physiology, having authored 17 papers that have together received 422 indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (6 papers), Immune responses and vaccinations (5 papers) and Tuberculosis Research and Epidemiology (4 papers). The work is most often cited by research in Immunology (237 citations), Infectious Diseases (167 citations) and Physiology (14 citations). Mardi C. Boer has collaborated with scholars based in Netherlands, Italy and United States. Frequent co-authors include Simone A. Joosten, Tom H. M. Ottenhoff, Krista E. van Meijgaarden, Jelle de Wit, Corine Prins, Nynke van Dijk, Jérémy Bastid, Jaap T. van Dissel, Christina Lancioni and Martijn Vos. Their work appears in journals such as The Journal of Immunology, PLoS ONE and Frontiers in Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026